Annual FCF
$14.21 M
-$501.00 K-3.41%
31 December 2023
Summary:
Core Laboratories NV annual free cash flow is currently $14.21 million, with the most recent change of -$501.00 thousand (-3.41%) on 31 December 2023. During the last 3 years, it has fallen by -$31.28 million (-68.76%). CLB annual FCF is now -94.66% below its all-time high of $266.01 million, reached on 31 December 2014.CLB Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
$10.37 M
-$3.91 M-27.37%
30 September 2024
Summary:
Core Laboratories NV quarterly free cash flow is currently $10.37 million, with the most recent change of -$3.91 million (-27.37%) on 30 September 2024. Over the past year, it has increased by +$14.04 million (+382.82%). CLB quarterly FCF is now -88.31% below its all-time high of $88.73 million, reached on 31 December 2014.CLB Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
$43.98 M
+$14.04 M+46.89%
30 September 2024
Summary:
Core Laboratories NV TTM free cash flow is currently $43.98 million, with the most recent change of +$14.04 million (+46.89%) on 30 September 2024. Over the past year, it has increased by +$35.43 million (+414.53%). CLB TTM FCF is now -84.32% below its all-time high of $280.53 million, reached on 31 March 2015.CLB TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLB Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -3.4% | +382.8% | +414.5% |
| 3 y3 years | -68.8% | +19.0% | +759.3% |
| 5 y5 years | -84.0% | -49.6% | -46.8% |
CLB Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -68.8% | at low | -38.5% | +292.9% | at high | +759.3% |
| 5 y | 5 years | -84.0% | at low | -56.3% | +167.9% | -46.8% | +759.3% |
| alltime | all time | -94.7% | +114.7% | -88.3% | +111.6% | -84.3% | +143.8% |
Core Laboratories NV Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $10.37 M(-27.4%) | $43.98 M(+46.9%) |
| June 2024 | - | $14.28 M(+477.0%) | $29.94 M(+35.7%) |
| Mar 2024 | - | $2.48 M(-85.3%) | $22.06 M(+55.3%) |
| Dec 2023 | $14.21 M(-3.4%) | $16.85 M(-559.5%) | $14.21 M(+66.3%) |
| Sept 2023 | - | -$3.67 M(-157.3%) | $8.55 M(-44.4%) |
| June 2023 | - | $6.40 M(-219.1%) | $15.38 M(+142.0%) |
| Mar 2023 | - | -$5.38 M(-148.1%) | $6.35 M(-56.8%) |
| Dec 2022 | $14.71 M(-35.3%) | $11.19 M(+253.7%) | $14.71 M(+151.1%) |
| Sept 2022 | - | $3.16 M(-220.7%) | $5.86 M(-48.7%) |
| June 2022 | - | -$2.62 M(-187.9%) | $11.41 M(-44.5%) |
| Mar 2022 | - | $2.98 M(+27.6%) | $20.57 M(-9.5%) |
| Dec 2021 | $22.72 M(-50.1%) | $2.33 M(-73.2%) | $22.72 M(+344.0%) |
| Sept 2021 | - | $8.72 M(+33.4%) | $5.12 M(-65.5%) |
| June 2021 | - | $6.53 M(+27.2%) | $14.82 M(-53.7%) |
| Mar 2021 | - | $5.14 M(-133.6%) | $32.02 M(-29.6%) |
| Dec 2020 | $45.49 M(-32.2%) | -$15.27 M(-182.9%) | $45.49 M(-41.1%) |
| Sept 2020 | - | $18.42 M(-22.4%) | $77.24 M(-2.7%) |
| June 2020 | - | $23.73 M(+27.6%) | $79.42 M(+20.9%) |
| Mar 2020 | - | $18.61 M(+12.9%) | $65.71 M(-2.0%) |
| Dec 2019 | $67.08 M(-24.5%) | $16.48 M(-20.0%) | $67.08 M(-18.8%) |
| Sept 2019 | - | $20.59 M(+105.2%) | $82.60 M(+1.2%) |
| June 2019 | - | $10.03 M(-49.8%) | $81.61 M(-9.6%) |
| Mar 2019 | - | $19.97 M(-37.6%) | $90.29 M(+1.6%) |
| Dec 2018 | $88.90 M(-15.4%) | $32.00 M(+63.3%) | $88.90 M(-9.5%) |
| Sept 2018 | - | $19.60 M(+4.8%) | $98.20 M(-5.1%) |
| June 2018 | - | $18.71 M(+0.7%) | $103.50 M(+3.0%) |
| Mar 2018 | - | $18.58 M(-55.0%) | $100.48 M(-4.4%) |
| Dec 2017 | $105.12 M(-12.5%) | $41.31 M(+65.9%) | $105.12 M(+26.3%) |
| Sept 2017 | - | $24.90 M(+58.6%) | $83.25 M(-8.2%) |
| June 2017 | - | $15.70 M(-32.4%) | $90.68 M(-9.5%) |
| Mar 2017 | - | $23.21 M(+19.4%) | $100.19 M(-16.6%) |
| Dec 2016 | $120.18 M(-38.3%) | $19.44 M(-39.9%) | $120.18 M(-17.5%) |
| Sept 2016 | - | $32.33 M(+28.2%) | $145.59 M(-2.8%) |
| June 2016 | - | $25.21 M(-41.6%) | $149.79 M(-9.5%) |
| Mar 2016 | - | $43.20 M(-3.7%) | $165.57 M(-15.0%) |
| Dec 2015 | $194.84 M(-26.8%) | $44.85 M(+22.8%) | $194.84 M(-18.4%) |
| Sept 2015 | - | $36.52 M(-10.9%) | $238.72 M(-11.0%) |
| June 2015 | - | $41.00 M(-43.4%) | $268.34 M(-4.3%) |
| Mar 2015 | - | $72.47 M(-18.3%) | $280.53 M(+5.5%) |
| Dec 2014 | $266.01 M(+2.6%) | $88.73 M(+34.2%) | $266.01 M(+4.0%) |
| Sept 2014 | - | $66.14 M(+24.4%) | $255.90 M(+0.7%) |
| June 2014 | - | $53.19 M(-8.2%) | $254.00 M(-1.6%) |
| Mar 2014 | - | $57.96 M(-26.3%) | $258.18 M(-0.4%) |
| Dec 2013 | $259.19 M(+26.8%) | $78.61 M(+22.4%) | $259.19 M(+0.4%) |
| Sept 2013 | - | $64.24 M(+12.0%) | $258.08 M(+9.6%) |
| June 2013 | - | $57.37 M(-2.7%) | $235.42 M(+8.5%) |
| Mar 2013 | - | $58.97 M(-23.9%) | $217.03 M(+6.2%) |
| Dec 2012 | $204.40 M(+17.5%) | $77.50 M(+86.4%) | $204.40 M(+18.5%) |
| Sept 2012 | - | $41.58 M(+6.7%) | $172.43 M(-0.6%) |
| June 2012 | - | $38.97 M(-15.9%) | $173.46 M(+4.0%) |
| Mar 2012 | - | $46.34 M(+1.8%) | $166.71 M(-4.2%) |
| Dec 2011 | $173.98 M(-2.3%) | $45.53 M(+6.9%) | $173.98 M(+10.7%) |
| Sept 2011 | - | $42.61 M(+32.2%) | $157.19 M(-4.9%) |
| June 2011 | - | $32.23 M(-39.9%) | $165.35 M(-5.8%) |
| Mar 2011 | - | $53.61 M(+86.5%) | $175.52 M(-1.4%) |
| Dec 2010 | $178.03 M | $28.74 M(-43.4%) | $178.03 M(-0.5%) |
| Sept 2010 | - | $50.77 M(+19.7%) | $178.90 M(-1.7%) |
| June 2010 | - | $42.40 M(-24.5%) | $182.07 M(+5.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2010 | - | $56.13 M(+89.5%) | $173.10 M(+5.3%) |
| Dec 2009 | $164.34 M(+32.6%) | $29.61 M(-45.1%) | $164.34 M(-3.5%) |
| Sept 2009 | - | $53.93 M(+61.3%) | $170.35 M(+17.4%) |
| June 2009 | - | $33.43 M(-29.4%) | $145.10 M(-4.2%) |
| Mar 2009 | - | $47.37 M(+33.0%) | $151.53 M(+22.3%) |
| Dec 2008 | $123.90 M(+22.0%) | $35.62 M(+24.2%) | $123.90 M(+5.4%) |
| Sept 2008 | - | $28.68 M(-28.0%) | $117.55 M(+6.7%) |
| June 2008 | - | $39.86 M(+102.0%) | $110.13 M(+4.3%) |
| Mar 2008 | - | $19.74 M(-32.6%) | $105.60 M(+4.0%) |
| Dec 2007 | $101.55 M(+6.2%) | $29.27 M(+37.7%) | $101.55 M(-2.6%) |
| Sept 2007 | - | $21.26 M(-39.8%) | $104.27 M(-0.8%) |
| June 2007 | - | $35.33 M(+125.2%) | $105.08 M(+15.8%) |
| Mar 2007 | - | $15.69 M(-51.0%) | $90.77 M(-5.1%) |
| Dec 2006 | $95.62 M(+71.7%) | $32.00 M(+45.0%) | $95.62 M(+26.0%) |
| Sept 2006 | - | $22.07 M(+5.0%) | $75.92 M(-0.4%) |
| June 2006 | - | $21.02 M(+2.4%) | $76.21 M(+12.4%) |
| Mar 2006 | - | $20.54 M(+67.0%) | $67.83 M(+21.8%) |
| Dec 2005 | $55.68 M(+28.6%) | $12.29 M(-45.0%) | $55.68 M(-1.7%) |
| Sept 2005 | - | $22.36 M(+76.8%) | $56.66 M(+30.1%) |
| June 2005 | - | $12.64 M(+50.8%) | $43.55 M(+1.5%) |
| Mar 2005 | - | $8.39 M(-36.8%) | $42.91 M(-0.9%) |
| Dec 2004 | $43.31 M(+4.4%) | $13.28 M(+43.7%) | $43.31 M(-2.0%) |
| Sept 2004 | - | $9.24 M(-23.1%) | $44.17 M(-7.6%) |
| June 2004 | - | $12.01 M(+36.8%) | $47.83 M(-3.8%) |
| Mar 2004 | - | $8.78 M(-37.9%) | $49.71 M(+19.9%) |
| Dec 2003 | $41.47 M(+56.5%) | $14.14 M(+9.7%) | $41.47 M(+3.7%) |
| Sept 2003 | - | $12.89 M(-7.2%) | $40.00 M(+24.7%) |
| June 2003 | - | $13.89 M(+2449.2%) | $32.08 M(+28.0%) |
| Mar 2003 | - | $545.00 K(-95.7%) | $25.05 M(-5.5%) |
| Dec 2002 | $26.50 M(-3745.4%) | $12.66 M(+154.7%) | $26.50 M(+54.2%) |
| Sept 2002 | - | $4.97 M(-27.6%) | $17.19 M(+92.3%) |
| June 2002 | - | $6.87 M(+244.6%) | $8.94 M(-1001.0%) |
| Mar 2002 | - | $1.99 M(-40.5%) | -$992.00 K(+36.5%) |
| Dec 2001 | -$727.00 K(-97.2%) | $3.35 M(-202.2%) | -$727.00 K(-82.1%) |
| Sept 2001 | - | -$3.28 M(+7.2%) | -$4.07 M(-51.6%) |
| June 2001 | - | -$3.06 M(-235.4%) | -$8.39 M(-65.5%) |
| Mar 2001 | - | $2.26 M(>+9900.0%) | -$24.29 M(-6.9%) |
| Dec 2000 | -$26.09 M(+74.4%) | $15.00 K(-100.2%) | -$26.09 M(-7.7%) |
| Sept 2000 | - | -$7.61 M(-59.9%) | -$28.27 M(+35.3%) |
| June 2000 | - | -$18.95 M(-4284.3%) | -$20.90 M(+240.0%) |
| Mar 2000 | - | $453.00 K(-120.9%) | -$6.15 M(-58.9%) |
| Dec 1999 | -$14.96 M(-42.1%) | -$2.17 M(+817.4%) | -$14.96 M(-51.3%) |
| Sept 1999 | - | -$236.00 K(-94.4%) | -$30.75 M(+23.4%) |
| June 1999 | - | -$4.20 M(-49.8%) | -$24.91 M(-13.8%) |
| Mar 1999 | - | -$8.36 M(-53.4%) | -$28.91 M(+11.9%) |
| Dec 1998 | -$25.85 M(-73.3%) | -$17.95 M(-420.5%) | -$25.85 M(-73.5%) |
| Sept 1998 | - | $5.60 M(-168.3%) | -$97.60 M(0.0%) |
| June 1998 | - | -$8.20 M(+54.7%) | -$97.60 M(-2.7%) |
| Mar 1998 | - | -$5.30 M(-94.1%) | -$100.30 M(+3.7%) |
| Dec 1997 | -$96.70 M(-6143.8%) | -$89.70 M(-1701.8%) | -$96.70 M(+1596.5%) |
| Sept 1997 | - | $5.60 M(-151.4%) | -$5.70 M(-52.1%) |
| June 1997 | - | -$10.90 M(+541.2%) | -$11.90 M(-3075.0%) |
| Mar 1997 | - | -$1.70 M(-230.8%) | $400.00 K(-75.0%) |
| Dec 1996 | $1.60 M(-70.4%) | $1.30 M(-316.7%) | $1.60 M(+433.3%) |
| Sept 1996 | - | -$600.00 K(-142.9%) | $300.00 K(-66.7%) |
| June 1996 | - | $1.40 M(-380.0%) | $900.00 K(-280.0%) |
| Mar 1996 | - | -$500.00 K | -$500.00 K |
| Dec 1995 | $5.40 M | - | - |
FAQ
- What is Core Laboratories NV annual free cash flow?
- What is the all time high annual FCF for Core Laboratories NV?
- What is Core Laboratories NV annual FCF year-on-year change?
- What is Core Laboratories NV quarterly free cash flow?
- What is the all time high quarterly FCF for Core Laboratories NV?
- What is Core Laboratories NV quarterly FCF year-on-year change?
- What is Core Laboratories NV TTM free cash flow?
- What is the all time high TTM FCF for Core Laboratories NV?
- What is Core Laboratories NV TTM FCF year-on-year change?
What is Core Laboratories NV annual free cash flow?
The current annual FCF of CLB is $14.21 M
What is the all time high annual FCF for Core Laboratories NV?
Core Laboratories NV all-time high annual free cash flow is $266.01 M
What is Core Laboratories NV annual FCF year-on-year change?
Over the past year, CLB annual free cash flow has changed by -$501.00 K (-3.41%)
What is Core Laboratories NV quarterly free cash flow?
The current quarterly FCF of CLB is $10.37 M
What is the all time high quarterly FCF for Core Laboratories NV?
Core Laboratories NV all-time high quarterly free cash flow is $88.73 M
What is Core Laboratories NV quarterly FCF year-on-year change?
Over the past year, CLB quarterly free cash flow has changed by +$14.04 M (+382.82%)
What is Core Laboratories NV TTM free cash flow?
The current TTM FCF of CLB is $43.98 M
What is the all time high TTM FCF for Core Laboratories NV?
Core Laboratories NV all-time high TTM free cash flow is $280.53 M
What is Core Laboratories NV TTM FCF year-on-year change?
Over the past year, CLB TTM free cash flow has changed by +$35.43 M (+414.53%)